Dual stem-cell transplant improves outlook for children with high-risk neuroblastoma
Children with high-risk neuroblastoma whose treatment included two autologous stem-cell transplants were more likely to be free of cancer three years later than patients who underwent a single transplant, a Phase 3 clinical trial has found. The tandem transplant technique produced even better results when followed by treatment with immunotherapy agents.
Source: ScienceDaily Headlines - Category: Science Source Type: news
More News: Cancer | Cancer & Oncology | Children | Clinical Trials | Immunotherapy | Neuroblastoma | Neurology | Science | Stem Cell Therapy | Stem Cells | Transplants